We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

175 hedge funds and large institutions have $1.12B invested in Natus Medical Inc in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 66 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $1.02B → $1.12B (+$98.4M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less funds holding

Funds holding: 184175 (-9)

13% less call options, than puts

Call options by funds: $2.38M | Put options by funds: $2.72M

17% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 66

32% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 28

Holders
175
Holders Change
-9
Holders Change %
-4.89%
% of All Funds
4.01%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
19
Increased
55
Reduced
66
Closed
28
Calls
$2.38M
Puts
$2.72M
Net Calls
-$342K
Net Calls Change
-$3.89M
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
101
Advisors Asset Management
Colorado
$415K -$34.5K -983 -8%
GCP
102
GSA Capital Partners
United Kingdom
$399K +$405K +11,555 New
SOADOR
103
State of Alaska Department of Revenue
Alaska
$377K +$8.41K +240 +2%
TA
104
Teton Advisors
New York
$366K
MLICM
105
Metropolitan Life Insurance Company (MetLife)
New York
$360K
MSA
106
Mason Street Advisors
Wisconsin
$333K +$16.3K +466 +5%
MERSOM
107
Municipal Employees' Retirement System of Michigan
Michigan
$325K -$134K -3,810 -29%
P
108
Pitcairn
Pennsylvania
$322K -$17.1K -487 -5%
O
109
OppenheimerFunds
New York
$320K -$4.73K -135 -1%
HC
110
Henshaw Capital
Massachusetts
$314K +$319K +9,090 New
AG
111
Aperio Group
California
$308K -$19.3K -550 -6%
SCC
112
Spring Creek Capital
Kansas
$301K +$305K +8,711 New
FCAG
113
First Capital Advisors Group
New Jersey
$290K +$18.7K +534 +7%
Public Employees Retirement Association of Colorado
114
Public Employees Retirement Association of Colorado
Colorado
$278K
PI
115
PineBridge Investments
New York
$268K -$17.6K -503 -6%
PIA
116
Piedmont Investment Advisors
North Carolina
$268K +$24.2K +690 +10%
Citigroup
117
Citigroup
New York
$265K -$82.1K -2,341 -23%
Citadel Advisors
118
Citadel Advisors
Florida
$254K -$1.26M -35,923 -83%
MCP
119
Mirador Capital Partners
California
$251K -$8.8K -251 -3%
COPPSERS
120
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$244K +$248K +7,079 New
PA
121
Profund Advisors
Maryland
$240K +$16.8K +480 +7%
GCA
122
Greenwood Capital Associates
South Carolina
$227K -$280 -8 -0.1%
CPH
123
C Partners Holding
Switzerland
$225K -$22.6K -646 -9%
PDM
124
Penn Davis McFarland
Texas
$224K +$228K +6,500 New
Teacher Retirement System of Texas
125
Teacher Retirement System of Texas
Texas
$218K -$20K -571 -8%

NTUS Hedge Fund Activity: Q2 2018 in Review

175 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2018, worth a combined $1.12B — up 9.7% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NTUS and 19 opened new positions — a net loss of 9 holders — while 66 trimmed existing stakes and 55 added.

The largest buyer was Eagle Asset Management, adding an estimated $44.9M. The largest seller was Corsair Capital Management, cutting an estimated $18.8M.

  • 175 institutional investors held Natus Medical Inc (NTUS) as of Q2 2018, down from 184 in Q1 2018.
  • Funds reported $1.12B of Natus Medical Inc stock for Q2 2018, up 9.7% quarter-over-quarter.
  • 19 funds opened new Natus Medical Inc positions in Q2 2018 and 28 closed out, a net change of -9 holders.
  • The largest Natus Medical Inc buyer in Q2 2018 was Eagle Asset Management, an estimated $44.9M added.
  • The largest Natus Medical Inc seller in Q2 2018 was Corsair Capital Management, an estimated $18.8M sold.

Based on aggregated 13F filings for Q2 2018.